Doer Biologis
Latest round
- Series A
Last raised
- Nov 2020
Total raised
- Undisclosed
Investors
- 4
About Doer Biologis
Based in Hangzhou, China and established in 2014, Doer Biologis is a biopharmaceutical company providing bio-macromolecule drugs., Ltd for RMB 490 million., Ltd became the largest shareholder of Doer Biologis. The company owns Xlongylation, a platform for the long-term modification of recombinant PEG-like modified (RPEG) proteins, MultipleBody, a multi-target technology platform, and HTS-VHHBody, a platform for the high-throughput discovery and modification of single-domain antibodies. And Accubody ®-- Tumor Precision Therapy Technology Platform and other innovative protein engineering platform technologies. Based on the technology, the company provides antibody drugs and multi-specific protein drugs for oncology, metabolism, ophthalmology.
Who invested in Doer Biologis
4 investors across 2 rounds
See all investors in Doer Biologis
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Doer Biologis
Who invested in Doer Biologis?
Doer Biologis has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Doer Biologis raised?
Doer Biologis has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Doer Biologis last raise money?
Doer Biologis's most recent round on record is a Series A, in Nov 2020.
What does Doer Biologis do?
Based in Hangzhou, China and established in 2014, Doer Biologis is a biopharmaceutical company providing bio-macromolecule drugs.
Where is Doer Biologis headquartered?
Doer Biologis is headquartered in Hangzhou, China.
Which VCs invest in companies like Doer Biologis?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Doer Biologis's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Doer Biologis? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.